Copeptin: clinical use of a new biomarker
Top Cited Papers
- 31 March 2008
- journal article
- Published by Elsevier BV in Trends in Endocrinology & Metabolism
- Vol. 19 (2), 43-49
- https://doi.org/10.1016/j.tem.2007.11.001
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related DisordersCurrent Pharmaceutical Design, 2005
- Causes of reversible nephrogenic diabetes insipidus: A systematic reviewAmerican Journal of Kidney Diseases, 2005
- Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiologyCritical Care, 2004
- The vasopressin V1b receptor as a therapeutic target in stress-related disorders.Current Drug Targets-CNS & Neurological Disorders, 2003
- Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiologyCritical Care, 2003
- Management of Vasodilatory ShockDrugs, 2003
- Diabetes insipidusHormone Research in Paediatrics, 2003
- Chapter 15 Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligandsProgress in Brain Research, 2002
- Drug-induced syndrome of inappropriate antidiuretic hormone secretionHeart, 1999
- Stress Hormone Response during and after Cardiopulmonary ResuscitationAnesthesiology, 1992